A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes

Kidney International

Volumn 69, Issue 1, 2006, Pages 129-136

  Krolewski, A S ^a,d   Poznik, G D ^a   Placha, G ^a   Canani, L ^a,e   Dunn, J ^a   Walker, W ^a   Smiles, A ^a   Krolewski, B ^a   Fogarty, D G ^a,f   Moczulski, D ^a,g   Araki, S ^a,h   Makita, Y ^a,i   Ng, D P K ^a,j   Rogus, J ^a   Duggirala, R ^b   Rich, S S ^c   Warram, J H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d JOSLIN DIABETES CENTER   (United States)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^g MEDICAL UNIVERSITY OF SILESIA   (Poland)

^h SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

ⁱ JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

more..

Author keywords

Genetics of diabetic nephropathy; QTL for urinary albumin excretion; QTLs on chromosomes 5q, 7q and 22q; Variance components linkage analysis

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ARTICLE; CAUCASIAN; CHROMOSOME 22Q; CHROMOSOME 5Q; CHROMOSOME 7Q; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; FAMILY; FEMALE; GENE CONTROL; GENETIC LINKAGE; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; HYPOTHESIS; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RELATIVE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; VARIANCE;

ADULT; AGED; ALBUMINURIA; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; MIDDLE AGED; QUANTITATIVE TRAIT LOCI;

EID: 30944464807     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000023     Document Type: Article

References (41)

1. Krolewski AS, Warram JH. Clinical features and epidemiology of diabetic nephropathy. In: Pickup JC, Williams G (eds). Textbook of Diabetes, 2nd edn. Blackwell Scientific Publications: Oxford; 1997, pp 53.1-53.13.
2. Parving HH, Mauer M, Ritz E. Diabetic nephropathy. In: Brenner BM (eds). Brenner and Rector's The Kidney, 7th edn. Elsevier Inc.: Amsterdam; 2004, pp 1777-1818.
3. Forsblom CM, Kanninen T, Lehtovitra M et al. Heritability of albumin excretion rate in families of patients with Type II diabetes. Diabetologia 1999; 42: 1359-1366.
4. Fogarty DG, Rich SS, Hanna L et al. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int 2000; 57: 250-257.
5. Freedman BI, Beck SR, Rich SS et al. A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension 2003; 42: 291-296.
6. Fox CS, Yang Q, Guo CY et al. Genome-wide linkage analysis for urinary microalbuminuria in a community-based sample: The Framingham Heart Study. Kidney Int 2005; 67: 70-74.
7. Fogarty DG, Hanna LS, Wantman M et al. Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes 2000; 49: 1057-1063.
8. Gruden G, Cavallo PP, Olivetti C et al. Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy. Diabetologia 1995; 38: 1218-1222.
9. Strojek K, Grzeszczak W, Morawin E et al. Nephropathy of type II diabetes: evidence for hereditary factors? Kidney Int 1997; 51: 1602-1607.
10. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-1165.
11. Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39: 940-945.
12. The Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 1997; 46: 1829-1839.
13. Harjutsalo V, Katoh S, Sarti C et al. Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes 2004; 53: 2449-2454.
14. Faronato P, Maioli M, Tonolo G et al. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. Diabetologia 1997; 40: 816-823.
15. Canani LH, Gerchman F, Gross JL. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes 1999; 48: 909-913.
16. Scott LJ, Warram JH, Hanna LS et al. A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 2001; 50: 2842-2849.
17. Klupa T, Warram JH, Antonellis A et al. Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect. Diabetes Care 2002; 25: 2292-2301.
18. Moczulski DK, Rogus JJ, Antonellis A et al. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 1998; 47: 1164-1169.
19. Zanchi A, Moczulski DK, Hanna LS et al. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with polymorphism in endothelial oxide synthase gene. Kidney Int 2000; 57: 405-413.
20. Wang Y, Kikuchi S, Suzuki H et al. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases. Nephrol Dial Transplant 1999; 14: 2898-2902.
21. Neugebauer S, Baba T, Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 2000; 49: 500-503.
22. Liu Y, Burdon KP, Langefeld CD et al. T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study. J Am Soc Nephrol 2005; 16: 1085-1090.
23. Asakimori Y, Yorioka N, Taniguchi Y et al. T(-786)-> C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron 2002; 91: 747-751.
24. Buraczynska M, Ksiazek P, Zaluska W et al. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol Dial Transplant 2004; 19: 2302-2306.
25. Rippin JD, Patel A, Belyaev ND et al. Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 2003; 46: 426-428.
26. Imperatore G, Hanson RL, Pettitt DK et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998; 47: 821-830.
27. Vardali I, Baier LJ, Hanson RL et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q223-23. Kidney Int 2002; 62: 2176-2183.
28. Osicka TM, Houlihan CA, Chan JG et al. Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 2000; 49: 1579-1584.
29. Krolewski AS, Laffel LM, Krolewski M et al. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1251-1255.
30. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type 1 diabetes on the prevalence of stages of diabetic nephropathy defined by albumin/creatinine ratio. J Am Soc Nephol 1996; 7: 930-937.
31. Blangero J, Almasy L. Multipoint oligogenic linkage analysis of quantitative traits. Genet Epidemiol 1997; 14: 959-964.
32. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211.
33. Pratt SC, Daly MJ, Kruglyak L. Exact multipoint quantitative-trait linkage analysis in pedigrees by variance components. Am J Hum Genet 2000; 66: 1153-1157.
34. Blangero J, Williams JT, Almasy L. Variance component methods for detecting complex trait loci. Adv Genet 2001; 42: 151-181.
35. Heath SC. Markov chain Monte Carlo segregation and linkage analysis for oligogenic models. Am J Hum Genet 1997; 61: 748-760.
36. Hopper JL, Mathews JD. Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet 1982; 46: 373-383.
37. Self SG, Liang KY. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions. J Am Stat Assoc 1987; 82: 605-610.
38. Boehnke M, Lange K. Ascertainment and goodness of fit of variance component models for pedigree data. Prog Clin Biol Res 1984; 147: 173-192.
39. Blangero J, MacCluer JW, Kammerer CM, Mott CE. Genetic analysis of apolipoprotein A-I in two dietary environments. Am J Hum Genet 1990; 47: 414-428.
40. Towne B, Almasy L, Siervogel RM, Blangero J. Effects of genotype-by-sex interaction on linkage analysis of visual event-related evoked potentials. Genet Epidemiol 1999; 17(Suppl 1): S355-S360.
41. Martin LJ, Kissebah AH, Sonnenberg GE et al. Genotype-by-smoking interaction for leptin levels in the metabolic risk complications of obesity genes project. Int J Obes Relat Metab Disord 2003; 27: 334-340.